Clinical Trial Update: N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome [EARLY_Phase 1]

View source ↗

Summary

A clinical trial evaluating N-Acetyl-cysteine for early acute respiratory distress syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Prisma Health-Midlands | Conditions: Acute Respiratory Distress Syndrome | EARLY_Phase 1 | Status: WITHDRAWN